Risk of developing low glomerular filtration rate or elevated serum creatinine in a screened cohort in Okinawa, Japan

Hypertension Research

Volumn 30, Issue 2, 2007, Pages 167-174

  Iseki, Kunitoshi ^a   Iseki, Chiho ^a   Ikemiya, Yoshiharu ^a   Kinjo, Kozen ^a   Takishita, Shuichi ^a  

^a UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

Author keywords

Chronic kidney disease; Glomerular filtration rate; Screening; Serum creatinine

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMMUNITY LIVING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; JAPAN; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SYSTOLIC BLOOD PRESSURE; URINALYSIS;

BIOLOGICAL MARKERS; BLOOD PRESSURE DETERMINATION; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; JAPAN; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MASS SCREENING; PROTEINURIA; RISK FACTORS;

EID: 34047213683     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.30.167     Document Type: Article

References (30)

1. Wakai K, Nakai S, Kikuchi K, et al: Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause. Nephrol Dial Transplant 2004; 16: 2044-2052.
2. US Renal Data System: Excerpts from the USRDS 2001 Annual Data Report: atlas of end-stage renal disease in the United States. Am J Kidney Dis 2001; 38 (Suppl 3): S1-S248.
3. Lysaght MJ: Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol 2002; 13 (Suppl 1): S37-S40.
4. Sarnak MJ, Levey AS, Schoolwerth AC, American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-2169.
5. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 204; 351: 1296-1305.
6. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D: Predictors of new-onset kidney disease in a community-based population. JAMA 2004; 291: 844-850.
7. Domrongkitchaiporn S, Sritara P, Kitiyakara C, et al: Risk factors for development of decreased kidney function in a Southeast Asian population: a 12-year cohort study. J Am Soc Nephrol 2005; 16: 791-799.
8. Iseki K: Factors influencing development of end-stage renal disease. Clin Exp Nephrol 2005; 9: 5-14.
9. Iseki K: The Okinawa screening program. J Am Soc Nephrol 2003; 14 (Suppl 2): S127-S130.
10. Iseki K, Iseki C, Ikemiya Y, Fukiyama K: Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 1996; 49: 800-805.
11. Iseki K, Ikemiya Y, Fukiyama K: Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening. Kidney Int 1997; 51: 850-854.
12. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12.
13. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis 2002; 39 (Suppl 1): S1-S266.
14. Iseki K, Ikemiya Y, Iseki C, Takishita S: Proteinuria and the risk of developing end-stage renal disease. Kidney Int 2003; 63: 1468-1474.
15. Chen J, Muntner P, Hamm LL, et al: The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004; 140: 167-174.
16. Tanaka H, Shiohira Y, Uezu Y, Higa A, Iseki K: Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int 2006; 69: 369-374.
17. Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, Takishita S: Triglyceride, but not total cholesterol or low-density lipoprotein levels, predict development of proteinuria. Kidney Int 2002; 62: 1743-1749.
18. Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, Takishita S: Influence of smoking and obesity on the development of proteinuria. Kidney Int 2002; 62: 956-962.
19. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S: Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004; 65: 1870-1876.
20. Ninomiya T, Kiyohara Y, Kubo M, et al: Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int 2005; 68: 228-236.
21. Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR: Screening for proteinuria in US adults. A cost-effectiveness analysis. JAMA 2003; 290: 3101-3114.
22. Yamagata K, Yamagata Y, Kobayashi M, Koyama A: A long-term follow-up study of asymptomatic hematuna and/or proteinuria in adults. Clin Nephrol 1996; 45: 281-288.
23. Gouva C, Nikolopoulos P, Ioannidis JPA, Siamopoulos KC: Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int 2004; 66: 753-760.
24. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J: Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002; 39: 1780-1786.
25. Ohtake T, Kobayashi S, Moriya H, et al: High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J Am Soc Nephrol 2005; 16: 1141-1148.
26. Orita Y, Okada M, Harada S, Horio M: Skim soy protein enhances GFR as much as beefsteak protein in healthy human subjects. Clin Exp Nephrol 2004; 8: 103-108.
27. Hosoya T, Toshima R, Icida K, Tabe A, Sakai O: Changes in renal function with aging among Japanese. Intern Med 1995; 34: 520-527.
28. Johnson RJ, Kang DH, Feig D, et al: Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183-1190.
29. Iseki K, Oshiro S, Tozawa M, Iseki C, Ikemiya Y, Takishita S: Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res 2001; 24: 691-697.
30. Sunagawa H, Iseki K, Nishime K, et al: Epidemiologic analysis of diabetic patients on chronic dialysis. Nephron 1996; 74: 361-366.